Biomarkers in Esophageal Adenocarcinoma
Author Information
Author(s): Williams L.J., Guernsey D.L., Casson A.G.
Primary Institution: Dalhousie University and the QEII Health Sciences Centre, Halifax, Nova Scotia
Hypothesis
Gastroesophageal reflux disease (GERD) leads to acute mucosal injury, promoting cellular proliferation and inducing specialized intestinal metaplasia of the esophagus.
Conclusion
High-grade dysplasia is the most reliable predictor of progression to invasive esophageal adenocarcinoma, but several molecular biomarkers may help identify patients at increased risk.
Supporting Evidence
- GERD is recognized as an important risk factor for Barrett esophagus.
- High-grade dysplasia is frequently associated with esophageal adenocarcinoma.
- Several molecular alterations have been identified in Barrett esophagus.
Takeaway
If you have a condition called Barrett esophagus, doctors are looking for special signs that might mean it could turn into cancer, so they can catch it early.
Methodology
The review discusses the molecular alterations associated with Barrett esophagus and their potential clinical applications.
Potential Biases
There is substantial intra- and inter-observer variability in grading dysplasia.
Limitations
The study highlights that the histologic diagnosis of dysplasia is subjective and can vary between observers.
Participant Demographics
The study mentions that male sex and increasing age are associated with an increased prevalence of Barrett esophagus.
Want to read the original?
Access the complete publication on the publisher's website